secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2022-08-24T23:59:59+00:00
Accession:  0001193125-22-228534
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam elects Dr. Elliott Sigal to Board, expanding size to 11 members
-----------------------------------------------------------------------

- Dr. Sigal elected as Class I director effective Aug 22, 2022; term expires at 2023 annual meeting.
- Annual cash fee of $55,000 for non-employee director service.
- Initial stock option for 4,456 shares at $217.91/share, $600K grant-date value, vesting over 3 years.
- Eligible for annual option award of $400K grant-date value beginning in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312522228534/0001193125-22-228534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312522228534/d335044d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-228534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer